Document is current
Any future updates will be listed below
-
Authors
García, Ana Victoria
Lambert, Carmen
Villa-Fernández, Elsa
García-Villarino, Miguel
Serrano-Olmedo, Isabel
Rubio, Elsa Fernández
Colet, Ana Megia
Brito-Sanfiel, Miguel
Mas, Francisca Payeras
Santos, Estefanía
de Salinas Santamaría, M. Ángeles Martínez
Gómez-Peralta, Fernando
Menéndez-Torre, Edelmiro
Pujante, Pedro
,
Madueño, Francisco Tinahones
Laureano, Florentino Carral San
de la Torre, Martín López
Carazo, Alberto Moreno
Hospital, Javier Acha Pérez
Nivela, Orosia Bandrés
Comas, Lluís Masmiquel
Gómez, Ignacio Llorente
Bayo, Juan Angel Hernández
Montalbán, Coral
de Luis, Daniel
Soto, Gonzalo Díaz
López-Guzmán, Antonio
Jiménez, Luz Ma López
Alvarez, Visitacion
Samper, Benito Blanco
Ballesteros, Ana Chico
Gómez, Belen Dalama
Conget, Ignacio
Maraver, Manuel Pérez
Soldevila, Berta
Flores, Ismael Capel
García, Marta Hernández
Ricart, Wifredo
Biescas, Elisenda Climent
Blasco, Francisco Javier Ampudia
Mijares, Antonio Hernández
Juan, Carlos Sánchez
Picó, Antonio
Escribano, José Ramón Domínguez
Montañana, Carmiña Fajardo
Pedro, Teresa
Abellán, Pablo
Rossetti, Paolo
Morales-Pérez, Francisco M.
Enciso, Fidel
González, Alfonso Soto
Guerrero, Diego Bellido
Cano, Reyes Luna
López, José Manuel García
Melero, Víctor M. Andía
Martín, José Alfonso Arranz
Mira, Sharona Azriel
Serrano, Marta Botella
Pascual, Alfonso Calle
del Cañizo Gómez, Francisco Javier
Fernández, Manuel Ángel Gargallo
Illán, Fátima
Martínez, Antonio M. Hernández
Llenas, Lluis Forga
Gómez, Clara Rosario Fuentes
Oleaga, Amelia
López-Siguero, Juan Pedro
Gómez-Gila, Ana Lucía
Sancho, Alfonso María Lechuga
Lozano, Marta Ferrer
Galán, Isolina Riaño
Caimari, María
Cardona, Roque
León, María Clemente
González, Gemma Carreras
Diez, Francisco Javier Arroyo
Rodríguez, Paloma Cabanas
Roldán, Belén
de Villar, Noemí González Pérez
Pérez, Purificación Ros
Rica, Itxaso
López, Ignacio Diez
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CD23/00037)
Ministerio de Educación y Formación Profesional (FPU)
Sanofi España (SED1 study)
Sanofi España (SED1 study)
Sanofi España (SED1 study)
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 28 February 2026
First Online: 13 March 2026
Declarations
:
: Fernando Gómez-Peralta has participated in Expert Panels for Abbott Diabetes, Novartis, Astra Zeneca, Sanofi and Novo Nordisk; participated as principalinvestigator in Clinical Trials funded by Sanofi, Novo Nordisk, BoehringerIngelheim Pharmaceuticals, and Lilly; and has participated as a speakerfor Abbott Diabetes, Novartis, Sanofi, Novo Nordisk, Boehringer Ingelheim The rest of the authors has no competing interestsPharmaceuticals, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co., and Lilly. Edelmiro Luis Menéndez Torre has participated as an investigator in clinicaltrials funded by Sanofi and Novo Nordisk, has participated as a speaker forAbbott Diabetes, Sanofi, Novo Nordisk, AstraZeneca, Menarini and Lilly; andhas received funding for education and research from Sanofi, Roche andMedtronic.
